YAP1 and hepatocellular carcinoma: In a pivotal research work, Zhang et al. described the synthesis of a cyclic peptidomimetic small molecule inhibitor of YAP–TEAD interaction and confirmed its therapeutic potential in vivo in a hepatocellular carcinoma xenograft model [146].